Ronan Kennedy

cbdMD, Inc. (NYSE:YCBD), an operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs announced its financial results on Wednesday for the third quarter of fiscal 2024 ending June 30, 2024. Year-over-year, operational losses improved markedly,...

IM Cannabis Medical cannabis company IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30, 2024, on Wednesday, Aug. 14, 2024. The company said it will host a Zoom web conference...

cbdMD, Inc. (NYSE: YCBD) announced its financial results for the second quarter of fiscal 2024, ending March 31, 2024. Despite an increase in operational losses from $1.4 million in Q2 fiscal 2023 to $1.5 million in Q2 fiscal 2024, management remains optimistic. "Transformation is not always...

cbdMD, Inc. (NYSE:YCBD) announced its first quarter financial results Tuesday for the three months ended Dec. 31, 2023. The North Carolina-based medical cannabis company said that it has improved its operating loss from $4.1 in the first quarter of 2023 to $1.1 million for the first quarter of...

Medical marijuana producer cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) said Friday that it had entered into a securities purchase agreement with five institutional investors to secure financing for the national rollout of its new ATRx Labs functional mushroom products. The company will use the proceeds for...

cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) reported its quarterly and full fiscal financial results on Friday for Sept. 30, 2023, revealing a 27% year-over-year drop in fourth-quarter net sales to $5.7 million. The company attributed the revenue decline to "industry trends, a reduction of marketing spend...

cbdMD, Inc. (AMEX: YCBD) (NYSE: YCBD) reported its financial and operating results Thursday afternoon for the Q3 fiscal 2023. cbdMD's Interim CEO and CFO Ronan Kennedy stated: "We have had a dynamic and eventful quarter, marked by significant capital markets activity, a strategic...

Charlotte-based CBD company cbdMD (AMEX: YCBD) reported its second-quarter fiscal 2023 results late Monday, revealing an improved net loss and significant reductions in selling, general and administrative (SG&A) costs. "This is one of the best operating results we have had since the...

cbdMD, Inc. (AMEX:YCBD) launched its novel food validated hemp-derived CBD products on Amazon.co.uk (NASDAQ: AMZN) in the United Kingdom. cbdMD gummies, tinctures, and topicals are now available on Amazon UK and qualify for next day delivery through Amazon Prime. cbdMD is one of only a handful of...